Skip to main content
Log in

Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is neurotoxic in animal studies and its use has been associated with cognitive impairments in humans.

Objective

To study hippocampal activation during the retrieval from episodic memory in polyvalent users of ecstasy.

Methods

Twelve polyvalent ecstasy users and twelve matched controls were examined by means of functional magnetic resonance imaging (fMRI) while they retrieved face-profession associations from episodic memory.

Results

Ecstasy users had a normal structural MRI scan without focal brain lesions or anatomical abnormalities. They exhibited equal retrieval accuracy during memory retrieval to that of the matched controls. Yet, their retrieval-related activity was lower and more spatially restricted in the left anterior hippocampus than that of the controls.

Conclusions

These results provide evidence for abnormal hippocampal functioning in MDMA users even at the presence of normal memory performance. This finding may be linked to MDMA-induced neurotoxicity and suggests that diminished hippocampal activation during memory retrieval might be a more sensitive or earlier index of MDMA-related neurotoxicity than neuropsychological performance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Bäckman L, Andersson JL, Nyberg L, Winblad B, Nordberg A, Almkvist O (1999) Brain regions associated with episodic retrieval in normal aging and Alzheimer’s disease. Neurology 52:1861–1870

    PubMed  Google Scholar 

  • Bhattachary S, Powell JH (2001) Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or “ecstasy”: evidence for cognitive impairment. Psychol Med 31:647–658

    Article  PubMed  CAS  Google Scholar 

  • Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA (“Ecstasy”) users. Neurology 51:1532–1537

    PubMed  CAS  Google Scholar 

  • Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW (2000) Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 17:502–503

    Google Scholar 

  • Buhot MC, Martin S, Segu, L (2000) Role of serotonin in memory impairment. Ann Med 32:210–221

    PubMed  CAS  Google Scholar 

  • Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF (2003) Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study. Drug Alcohol Depend 72:225–235

    Article  PubMed  CAS  Google Scholar 

  • Curran HV, Travill RA (1997) Mood and cognitive effects of ±3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”): week-end “high” followed by mid-week low. Addiction 92:821–831

    Article  PubMed  CAS  Google Scholar 

  • Dafters RI, Duffy F, O’Donnell PJ, Bouquet C (1999) Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology 145:82–90

    Article  PubMed  CAS  Google Scholar 

  • Daumann J, Fimm B, Willmes K, Thron A, Gouzoulis-Mayfrank E (2003) Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study. Brain Res Cogn Brain Res 16:479–487

    Article  PubMed  CAS  Google Scholar 

  • Daumann J, Fischermann T, Pilatus U, Thron A, Moeller-Hartmann W, Gouzoulis-Mayfrank E (2004) Proton magnetic resonance spectroscopy in ecstasy (MDMA) users. Neurosci Lett 362:113–116

    Article  PubMed  CAS  Google Scholar 

  • Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). J Neurosci 15:5476–5485

    PubMed  CAS  Google Scholar 

  • Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ (2002) Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology 162:203–214

    Article  PubMed  CAS  Google Scholar 

  • Gould E (1999) Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 21:46S–51S

    PubMed  CAS  Google Scholar 

  • Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert H-J, Fimm B, Sass H (2000) Impaired cognitive performance in drug-free recreational ecstasy (MDMA) users. J Neurol Neurosurg Psychiatry 68:719–725

    Article  PubMed  CAS  Google Scholar 

  • Gouzoulis-Mayfrank E, Timm B, Rezk M, Hensen G, Daumann J (2003) Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 27:819–827

    Article  PubMed  CAS  Google Scholar 

  • Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP (1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5:101–107

    Article  PubMed  CAS  Google Scholar 

  • Hatzidimitriou G, McCann UD, Ricaurte G (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with 3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096–5107

    PubMed  CAS  Google Scholar 

  • Henke K, Buck A, Weber B, Wieser HG (1997) Human hippocampus establishes associations in memory. Hippocampus 7:249–256

    Article  PubMed  CAS  Google Scholar 

  • Henke K, Treyer V, Nagy ET, Kneifel S, Dursteler M, Nitsch RM, Buck A (2003) Active hippocampus during nonconscious memories. Conscious Cogn 12:31–48

    Article  PubMed  Google Scholar 

  • Jacobson LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects. Psychopharmacology 173:383–390

    Article  PubMed  CAS  Google Scholar 

  • McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings. Lancet 352:1433–1437

    Article  PubMed  CAS  Google Scholar 

  • McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) users: a controlled study. Psychopharmacology 143:417–425

    Article  PubMed  CAS  Google Scholar 

  • McCann UD, Eligulashvili V, Ricaurte GA (2000) 3,4-Methylenedioxymethamphetamine (Ecstasy)-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42:11–16

    Article  PubMed  CAS  Google Scholar 

  • McCardle K, Luebbers S, Carter JD, Croft RJ, Stough C (2004) Chronic MDMA (ecstasy) use, cognition and mood. Psychopharmacology 173:434–439

    Article  PubMed  CAS  Google Scholar 

  • Morgan MJ (1998) Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252–264

    Article  PubMed  CAS  Google Scholar 

  • Morgan MJ (1999) Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology 141:30–36

    Article  PubMed  CAS  Google Scholar 

  • Parrott AC, Lasky J (1998) Ecstasy (MDMA) effects upon mood and cognition:before, during and after a Saturday night dance. Psychopharmacology139:261–268

  • Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J (2001) Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”). Arch Gen Psychiatry 58:901–906

    Article  PubMed  CAS  Google Scholar 

  • Ricaurte GA, Martello AL, Katz JL, Martello MB (1992) Lasting effects of MDMA on central serotonergic neurons in nonhuman primates: neurochemical observations. J Pharmacol Exp Ther 261:616–622

    PubMed  CAS  Google Scholar 

  • Ricaurte GA, Yuan J, McCann UD (2000) 3,4-methylenedioxymethamphetamine (Ecstasy)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5–10

    Article  PubMed  CAS  Google Scholar 

  • Riedel WJ, Klaasen T, Deutz NEP, van Someren A, van Praag HM (1999) Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation. Psychopharmacology 141:362–369

    Article  PubMed  CAS  Google Scholar 

  • Rodgers J (2001) Cognitive performance amongst recreational users of “ecstasy”. Psychopharmacology 151:19–24

    Article  Google Scholar 

  • Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. Thieme, Stuttgart

    Google Scholar 

  • Verkes RJ, Gijsman HJ, Pieters RC, de Visser S, Kuijpers M, Pennings JM, de Bruin D, van de Winjngaart G, van Grven JMA, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196–202

    Article  PubMed  CAS  Google Scholar 

  • Vertes RP, Kocsis B (1997) Brainstem-diencephalo-septohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 81:893–899

    Article  PubMed  CAS  Google Scholar 

  • Villemagne V, Yuan J, Wong DF, Dannals RF, Hatzidimitrou G, Matthews WB, Ravert HT, Musachio J, McCann UD, Ricaurte GA (1998) Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C] WIN 35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18:419–427

    PubMed  CAS  Google Scholar 

  • Volkow ND, Fowler JS (2002) Application of imaging technologies in the investigation of drug addiction. In: Davis KL, Charney D, Coyle JT (eds) Neuropsychopharmacology: the fifth generation of progress, An official publication of the American College of Neuropsychopharmacology. Lippincott Williams & Wilkins, Philadelphia, pp 1475–1490

    Google Scholar 

  • Wareing M, Fisk JE, Murphy PN (2000) Working memory deficits in current and previous users of MDMA (“ecstasy”). Br J Psychol 91:181–188

    Article  PubMed  Google Scholar 

  • Wareing M, Murphy PN, Fisk JE (2004) Visuospatial memory impairments in users of MDMA (‘ecstasy’). Psychopharmacology 173:391–397

    Article  PubMed  CAS  Google Scholar 

  • Zakzanis KK, Young DA (2001a) Memory impairment in abstinent MDMA (“ecstasy”) users: a longitudinal investigation. Neurology 56:966–969

    PubMed  CAS  Google Scholar 

  • Zakzanis KK, Young DA (2001b) Executive function in abstinent MDMA (“ecstasy”) users. Med Sci Monit 7:1292–1298

    PubMed  CAS  Google Scholar 

  • Zakzanis K, Young DA, Radkhoshnoud NF (2002) Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users. Appl Neuropsychol 9:84–91

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by a grant to E. Gouzoulis-Mayfrank from the Deutsche Forschungsgemeinschaft (DFG GO 717/4-1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Euphrosyne Gouzoulis-Mayfrank.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Daumann, J., Fischermann, T., Heekeren, K. et al. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users. Psychopharmacology 180, 607–611 (2005). https://doi.org/10.1007/s00213-004-2002-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-004-2002-8

Keywords

Navigation